BankOnIP Patent Owner Invents Ocutrack™ – The OEM Eye Tracking Technology

 Breaking News
  • No posts were found

BankOnIP Patent Owner Invents Ocutrack™ – The OEM Eye Tracking Technology

June 17
17:15 2020

Stilwell, KS – June 17, 2020 – BankOnIP, a leading intellectual property broker, announced today the Ocutrack™. The Ocutrack™ is a system for tracking the 3D position and gaze angles of the eyes over their full range of movement. This information can be recorded by a Smartphone, tablet, computer, remote access video displays, and analyzed for eye position and eye movement dynamics.

The information gathered assists in the diagnosis of brain damage, drug toxicity, and other abnormalities across variety of domains, from optometry, ophthalmology, psychiatry, and neurology to sports medicine, either on-site or for remote diagnosis and monitoring. The Ocutrack™ is a simpler, easier way to perform this task in-person or remotely, requiring no additional equipment beyond an off-the-shelf electronic device.


  • Software app using existing tablet, smartphone or computer hardware platforms
  • No additional equipment necessary
  • Uses visible light rather than requiring specialized infrared emitters
  • Self-calibration solution
  • Accurate results
  • Tracks both eyes simultaneously
  • Tracks head position
  • Much lower cost than any current method
  • Proven technology
  • Easy to use in a wide range of environments
  • Ideal for remote monitoring

Product Details

Ocutrack™ is an eye tracking program that analyzes a video of a person’s face and produces conclusions that help with diagnosis of certain diseases and abnormalities. The tracking system is based on a 3D model of the configurations of the eyeballs, irises, pupils, axis geometries, and eyelids of both eyes.

The video file is analyzed to compare the information in each frame with the 2D image of the eye region. By adjusting the parameters of the 3D model, frame by frame comparisons are used to estimate the gaze angle, eyelid aperture, and pupil diameter of each eye. Analysis results can provide medical personnel information to diagnose and monitoring of treatments for various injuries, diseases and conditions that require oculomotor correction.

This system is designed for operation in many medical fields, and pertains particularly to patients who have received a traumatic brain injury to the eyes and brain, and to the debilitative diseases of aging of the oculomotor control system. Ocutrack™ provides enhanced, quantitative diagnosis of disorders such as strabismus, nystagmus, and gaze angles by tracking gaze angles from each frame over a period of time. The current eye-tracking configuration has been developed for the diagnosis of the oculomotor effects of concussion, or traumatic brain injury. Given adequate sensitivity and specificity, the product could be tremendously successful across the neurology and sports medicine applications.

Cost to product the Ocutrack™ is estimated to be between $120 and $125 per unit.

For additional information, licensing opportunities, and a full prospectus on the THE Ocutrack™

About BankOnIP

Headquartered in Stilwell, KS, BankOnIP is a leading intellectual property broker specializing in Intellectual Property (IP) commercialization of new patents and technologies. Our team brings extensive experience in brokering IP and commercialization of technologies.

Media and Investor Contact:

Vice President of Business Development
17745 Metcalf Avenue
Building #1
Stilwell, KS, 66085

Phone: 913.201.8025
Fax: 913.928.6296
Email: [email protected]

Media Contact
Company Name: BankOnIP
Contact Person: AMY SCHLEICHER, Vice President of Business Development
Email: Send Email
Phone: 913.201.8025
Country: United States

Related Articles